Vericel (VCEL) Receivables (2010 - 2026)
Vericel's (VCEL) quarterly Receivables came in at $72.4 million in Q1 2026, up 36.83% year-on-year from $52.9 million in Q1 2025, and down 14.48% quarter-over-quarter from $84.6 million in Q4 2025.
Vericel (VCEL) Receivables (2010 - 2026) Analysis & Trends
Vericel has disclosed Receivables across 17 years of filings, most recently posting $72.4 million for Q1 2026.
- Receivables for Q1 2026 came in at $72.4 million, up 36.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $72.4 million (up 36.83% YoY), and the FY2025 annual result was $84.6 million, up 37.9% from the prior year.
- Receivables came in at $72.4 million for Q1 2026 at Vericel, down from $84.6 million in the prior quarter.
- In the past five years, Receivables ranged from a high of $84.6 million in Q4 2025 to a low of $31.9 million in Q1 2022.
- The 5-year median for Receivables is $48.5 million (2024), against an average of $50.8 million.
- Across the five-year window, Receivables climbed 5.17% in 2024 and surged 37.9% in 2025, its largest moves.
- Vericel's Receivables stood at $46.5 million in 2022, then grew by 25.39% to $58.4 million in 2023, then increased by 5.17% to $61.4 million in 2024, then surged by 37.9% to $84.6 million in 2025, then declined by 14.48% to $72.4 million in 2026.
- The last three Receivables figures came in at $72.4 million (Q1 2026), $84.6 million (Q4 2025), and $60.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 13.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.00 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Vericel | 2.04 Bn | 1.90 Bn | 49.27 Mn | 72.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 72.38 Mn |
| Dec 31, 2025 | 84.63 Mn |
| Sep 30, 2025 | 60.43 Mn |
| Jun 30, 2025 | 64.29 Mn |
| Mar 31, 2025 | 52.90 Mn |
| Dec 31, 2024 | 61.38 Mn |
| Sep 30, 2024 | 48.48 Mn |
| Jun 30, 2024 | 48.00 Mn |
| Mar 31, 2024 | 49.93 Mn |
| Dec 31, 2023 | 58.36 Mn |
| Sep 30, 2023 | 39.73 Mn |
| Jun 30, 2023 | 38.32 Mn |
| Mar 31, 2023 | 38.36 Mn |
| Dec 31, 2022 | 46.54 Mn |
| Sep 30, 2022 | 34.30 Mn |
| Jun 30, 2022 | 33.66 Mn |
| Mar 31, 2022 | 31.86 Mn |
| Dec 31, 2021 | 37.44 Mn |
| Sep 30, 2021 | 28.91 Mn |
| Jun 30, 2021 | 31.73 Mn |